[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@kajacek2002](/creator/twitter/kajacek2002) "With XX % gross margin zero debt and optimized burn rate (30 % YoY) $MYNZ sets a rare example of capital discipline among micro-cap biotechs" [X Link](https://x.com/kajacek2002/status/1979189471254806750) [@kajacek2002](/creator/x/kajacek2002) 2025-10-17T14:15Z XX followers, 3233 engagements "$MARA $RIVN $CRWD $NIO" [X Link](https://x.com/kajacek2002/status/1979189754458497432) [@kajacek2002](/creator/x/kajacek2002) 2025-10-17T14:16Z XX followers, 2955 engagements "$MYNZ operates with precision low leverage positive gross margins and growing commercial traction in Europe. Catalysts are structural not speculative: CMS FDA and PancAlert data within XX months" [X Link](https://x.com/kajacek2002/status/1979257507773087895) [@kajacek2002](/creator/x/kajacek2002) 2025-10-17T18:45Z XX followers, 1123 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@kajacek2002
"With XX % gross margin zero debt and optimized burn rate (30 % YoY) $MYNZ sets a rare example of capital discipline among micro-cap biotechs"
X Link @kajacek2002 2025-10-17T14:15Z XX followers, 3233 engagements
"$MARA $RIVN $CRWD $NIO"
X Link @kajacek2002 2025-10-17T14:16Z XX followers, 2955 engagements
"$MYNZ operates with precision low leverage positive gross margins and growing commercial traction in Europe. Catalysts are structural not speculative: CMS FDA and PancAlert data within XX months"
X Link @kajacek2002 2025-10-17T18:45Z XX followers, 1123 engagements
/creator/twitter::2974577398/posts